John Clerici is a founding Principal of Tiber Creek Partners. For over two decades, John has been at the forefront in the creation of the public health preparedness sector, including helping large pharmaceutical and emerging biotechnology companies develop creative approaches to access non-dilutive capital to fund the development of biotechnology for emerging disease and engineered threats. Since 1999, John has assisted over three dozen companies in obtaining nearly $4 billion in funding for research, development and procurement of public health countermeasures to the federal government, including the majority of the awards made under Project Bioshield, the United States Government’s initiative for preparing the Nation against a bioterrorist attack.

In 2005, John played a substantial role in the drafting and passage of the Public Readiness and Emergency Preparedness Act (PREP Act), landmark legislation that provides substantial liability protections for makers and distributors of pandemic, epidemic, and bioterrorism countermeasures. John testified as an expert in support of this legislation on four occasions before the United States Senate Appropriations Committee, Health, Education, Labor, and Pensions (HELP) Committee, and Judiciary Committee.

In 2006, John was instrumental in the passage of legislation creating the Biomedical Advanced Research and Development Authority (BARDA), which builds upon and improves Project BioShield. John’s expertise in the area of public health preparedness has been recognized by leading news outlets such as the Wall Street Journal, Business Week, The Associated Press, The Boston Globe, and The Hill. He has also appeared live on the Fox News Channel as a bioterrorism expert.